Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Current Leases: 2023-2025

Historic Current Leases for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $159,000.

  • Tonix Pharmaceuticals Holding's Current Leases fell 42.18% to $159,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $159,000, marking a year-over-year decrease of 42.18%. This contributed to the annual value of $274,000 for FY2024, which is 1.48% up from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Current Leases stood at $159,000 for Q3 2025, which was down 18.46% from $195,000 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Current Leases registered a high of $438,000 during Q1 2023, and its lowest value of $159,000 during Q3 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Current Leases value was $275,000 (recorded in 2024), while the average stood at $297,273.
  • Its Current Leases has fluctuated over the past 5 years, first rose by 1.48% in 2024, then plummeted by 42.18% in 2025.
  • Tonix Pharmaceuticals Holding's Current Leases (Quarterly) stood at $270,000 in 2023, then increased by 1.48% to $274,000 in 2024, then crashed by 42.18% to $159,000 in 2025.
  • Its last three reported values are $159,000 in Q3 2025, $195,000 for Q2 2025, and $235,000 during Q1 2025.